News

Chiasma, Inc. and Lonza announced that the companies have entered into a commercial supply agreement for Chiasma’s oral somatostatin analog candidate, conditionally trade named…
Read More...

Zymeworks Inc. announced that it has entered into a licensing agreement that grants Iconic Therapeutics, Inc. (Iconic) non-exclusive rights to Zymeworks’ proprietary ZymeLink…
Read More...

Hoth Therapeutics, announced that the company has signed a term sheet with Zylö Therapeutics Inc (Zylö) to co-develop a new treatment for patients suffering from Cutaneous Lupus…
Read More...

AbbVie announced that it has resolved U.S. HUMIRA (adalimumab) litigation with Boehringer Ingelheim (BI). Under the terms of the resolution, AbbVie will grant BI a non-exclusive license…
Read More...

Exelixis, Inc. announced its partner Daiichi Sankyo Company, Limited has launched MINNEBRO (esaxerenone) tablets as a treatment for patients with hypertension in Japan. With Daiichi…
Read More...

ElevateBio announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and…
Read More...

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to POMALYST (pomalidomide) for the treatment of patients with…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from…
Read More...

BioNTech SE announced the acquisition of antibody assets and infrastructure from San Diego-based MabVax Therapeutics Holding, a clinical-stage oncology drug development company.…
Read More...

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib Tablets are a kinase inhibitor…
Read More...

Adimab announced the expansion of an earlier multi-target research agreement with Regeneron Pharmaceuticals. Adimab and Regeneron commenced an initial agreement in December 2014,…
Read More...

Bayer announced it will invest $150 million in its Berkeley, CA pharmaceutical development and manufacturing site to build a Cell Culture Technology Center that will be used to…
Read More...

Pfizer Inc. announced the opening of a new 175,000 square-foot manufacturing facility in Andover, Mass. Pfizer’s Andover site houses commercial manufacturing and product development…
Read More...

Armata Pharmaceuticals announced that the previously-announced merger between C3J Therapeutics, Inc. and AmpliPhi Biosciences Corporation has closed. The new combined company, known as…
Read More...

WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation, has enrolled its first patient in the pivotal clinical study of…
Read More...

Sartorius Stedim Biotech (SSB) announced the new SIMCA 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics. The updated SIMCA…
Read More...

Pfizer announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on rare…
Read More...

Akcea Therapeutics and Ionis Pharmaceuticals announced that WAYLIVRA has received conditional marketing authorization from the European Commission (EC) as an adjunct to diet in adult…
Read More...

Novartis announced results from a validation study of the innovative, algorithm-based digital solution MS Progression Discussion Tool, or MSProDiscuss. The tool aims to support and…
Read More...

Merck, known as MSD outside the United States and Canada, announced the presentation of results of a Phase 3 trial evaluating the efficacy and safety of BELSOMRA (suvorexant) C-IV for…
Read More...